Peplomycin-induced apoptosis in oral squamous carcinoma cells depends on bleomycin sensitivity.

[1]  H. Hamakawa,et al.  Histological effects and predictive biomarkers of TPP induction chemotherapy for oral carcinoma. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[2]  H. Ito,et al.  Pre-operative radio-chemotherapy enhances apoptotic cell death in oral squamous cell carcinoma. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[3]  J. Fukuda,et al.  Fas antigen expression and outcome of oral squamous cell carcinoma. , 2000, International journal of oral and maxillofacial surgery.

[4]  J. Fukuda,et al.  Fas expression and Fas monoclonal antibody-induced apoptosis in a human squamous cell carcinoma cell line, SCC-25. , 2000, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[5]  B. Uhal,et al.  Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[6]  S. Nagata.  Apoptotic DNA fragmentation. , 2000, Experimental cell research.

[7]  G. Walkinshaw,et al.  Therapeutic applications of apoptosis research. , 2000, Experimental cell research.

[8]  W. Earnshaw,et al.  Induction of apoptosis by cancer chemotherapy. , 2000, Experimental cell research.

[9]  M. Chou,et al.  Induction of apoptosis in KB cells by pingyangmycin. , 2000, Oral oncology.

[10]  J. Fukuda,et al.  Induction of apoptosis in human oral squamous carcinoma cell lines by protein phosphatase inhibitors. , 1999, Oral oncology.

[11]  J. Fukuda,et al.  Localization of Fas antigen in oral squamous cell carcinoma. , 1999, The British journal of oral & maxillofacial surgery.

[12]  J. Inoue,et al.  Induction of Apoptosis in Human Pancreatic Carcinoma Cells by a Synthetic Bleomycin‐like Ligand , 1998, Japanese journal of cancer research : Gann.

[13]  G. Melino,et al.  Induction of apoptosis by bleomycin in resting and cycling human lymphocytes. , 1998, Mutagenesis.

[14]  S. Ikeda,et al.  Action of mitochondrial endonuclease G on DNA damaged by L-ascorbic acid, peplomycin, and cis-diamminedichloroplatinum (II). , 1997, Biochemical and biophysical research communications.

[15]  M. Raff,et al.  Programmed Cell Death in Animal Development , 1997, Cell.

[16]  R. Hamilton,et al.  Bleomycin induces apoptosis in human alveolar macrophages. , 1995, The American journal of physiology.

[17]  E. Munekata,et al.  Trophic effects of substance P and beta-amyloid peptide on dibutyryl cyclic AMP-differentiated human leukemic (HL-60) cells. , 1995, Life sciences.

[18]  H. Steller.  Mechanisms and genes of cellular suicide , 1995, Science.

[19]  H. Kishimoto,et al.  Induction of bleomycin resistance in a human oral squamous carcinoma cell line and characterisation of bleomycin-resistant and -sensitive clones. , 1994, European journal of cancer. Part B, Oral oncology.

[20]  D. Fisher.  Apoptosis in cancer therapy: Crossing the threshold , 1994, Cell.

[21]  C. Winterford,et al.  Apoptosis. Its significance in cancer and cancer Therapy , 1994, Cancer.

[22]  D. Petering,et al.  DNA double-strand breakage by bleomycin in Ehrlich ascites tumor cells as measured by nondenaturing filter elution. , 1994, Radiation research.

[23]  L. Mir,et al.  Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. , 1993, Cancer research.

[24]  M. Urade,et al.  Establishment of human squamous carcinoma cell lines highly and minimally sensitive to bleomycin and analysis of factors involved in the sensitivity , 1992, Cancer.

[25]  H. Yamaki,et al.  A peplomycin-supersensitive cell line lacking activation of poly(adenosine diphosphate ribose) synthetase by peplomycin. , 1988, Biochemical and biophysical research communications.

[26]  K. Solez,et al.  International Review of Experimental Pathology , 1986 .

[27]  P. Lin,et al.  Effects of iron, copper, cobalt, and their chelators on the cytotoxicity of bleomycin. , 1983, Cancer research.

[28]  W. Tanaka.  Development of new bleomycins with potential clinical utility. , 1977, The Japanese journal of antibiotics.

[29]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[30]  H. Tobi,et al.  A comparison of bleomycin-induced damage in lymphocytes and primary oral fibroblasts and keratinocytes in 30 subjects. , 1999, Mutagenesis.

[31]  J. Fukuda,et al.  Relationship between expression of FAS antigen and apoptosis in oral squamous cell carcinoma , 1999 .

[32]  A. Wyllie,et al.  Apoptosis: mechanisms and roles in pathology. , 1991, International review of experimental pathology.

[33]  Zhang Bo,et al.  DNA damage by peplomycin and its repair in an in vitro system. , 1991 .

[34]  Y. Sugiura,et al.  DNA-bleomycin interaction: Nucleotide sequence-specific binding and cleavage of DNA by bleomycin , 1984 .